Need professional-grade analysis? Visit stockanalysis.com
$141.46M
N/A
N/A
714.00%
Oramed Pharmaceuticals Inc (ORMP) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $3.85, down 0.77% from the previous close.
Over the past year, ORMP has traded between a low of $1.92 and a high of $3.88. The stock has gained 78.8% over this period. It is currently 100.5% above its 52-week low.
Oramed Pharmaceuticals Inc has a market capitalization of $141.46M and a dividend yield of 714.00%.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Side-by-side comparison against top Healthcare peers.